Efficacy and safety of Prostate stereotactic body radiotherapy for metastatic castration-resistant prostate cancer: A prospective cohort study.

Jun Li,JunYong Dai,Peng Xian,Lin Xiong,YanPing Song,XianLi Tang,Yuan Li,Yongzhong Wu,Hong Zhou,Nan Liu

Cancer treatment and research communications（2021）

引用 4|浏览0

暂无评分

摘要

Adding prostate SBRT significantly prolonged the time to symptomatic progression and non-significantly prolonged PFS and OS among men with mCRPC compared to treatment with ADT plus chemotherapy alone.

查看译文

关键词

Metastatic castration-resistant prostate cancer,Overall survival,Primary tumor,Progression-free survival,Stereotactic body radiotherapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要